Economic Benefits of a Routine Second Dose of Combined Measles, Mumps and Rubella Vaccine in Canada

Canadian Journal of Infectious Diseases
doi 10.1155/1997/215175
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Second Dose of Measles, Mumps, and Rubella Vaccine: Questionnaire Survey of Health Professionals

BMJ
2001English

Measles, Mumps and Rubella Vaccine

Drugs and Therapy Perspectives
Pharmacology
1993English

Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine — Illinois, 2015–2016

MMWR. Morbidity and mortality weekly report
Health Information ManagementMutagenesisEpidemiologyHealthMedicineToxicology
2016English

Measles, Mumps and Rubella

2010English

Benefits, Risks and Costs of Immunization for Measles, Mumps and Rubella.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1985English

Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures

Pediatrics
Child HealthPediatricsPerinatology
2010English

Effectiveness of Measles, Mumps and Rubella Vaccine as Immunotherapeutic Agent for Cutaneous Viral Warts

International Journal of Research in Dermatology
2020English

Intralesional Measles, Mumps and Rubella (Mmr) Vaccine - An Effective Therapeutic Tool in the Treatment of Wart

Journal of Evidence Based Medicine and Healthcare
2015English

Editorial: Measles, Rubella and Mumps in the Era of Elimination

The Open Vaccine Journal
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy